Is a complete RCEL research report available?

No complete published report is available for AVITA Medical, Inc. (RCEL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AVITA Medical, Inc. (RCEL)

NASDAQ: RCEL · USD

$4.61

-0.33 (-6.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RCEL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	141.9M
Revenue (ttm)	72.3M
Net income (ttm)	-45.3M
EPS (ttm)	-$1.57
Shares out	30.8M
Volume	186,167
Beta	1.86
Price target	$9.07	+96.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 72.3M
Net income (ttm): -45.3M
EPS (ttm): -$1.57
Market cap: 141.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RCEL indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001762303
Company name	AVITA Medical, Inc.
Country	United States
Country code	US
Cusip	05380C102
Employees	226
Employees Change	-34%
Employees Change Percent	-13.08
Enterprise value	$175.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	39.87
Industry PE Fwd	18.53
Isin	US05380C1027
Last refreshed	2026-07-24
Market cap	$141.9M
Market cap category	Micro-Cap
Price	$4.61
Price currency	USD
Rev Per Employee	320,119.47x
Sector	Healthcare
Sector PE	44.59
Sector PE Fwd	23.48
Sic	3841
Symbol	RCEL
Website	https://avitamedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-31.95%
EV Sales Forward	1.99x
EV/Sales	2.43x
FCF yield	-22.38%
P/S ratio	1.96x
PS Forward	1.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-54.62%
EBITDA Margin	-54.62%
Gross margin	81.36%
Gross Profit	$58.9M
Gross Profit Growth	-3.89%
Gross Profit Growth Q	0.3%
Gross Profit Growth3 Y	23.17%
Gross Profit Growth5 Y	26.69%
Net Income	$-45.3M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-62.68%
Profit Margin	-62.67%
Profit Per Employee	$-200,615
ROA	-40.78
ROCE	261.2
ROIC	-76.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.62%
Cagr1y	-20.67%
Cagr3y	-37.42%
Cagr5y	-25.08%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth	0.96x
Revenue Growth Q	3.98x
Revenue Growth Quarters	1x
Revenue Growth Years	9x
Revenue Growth3 Y	24.56x
Revenue Growth5 Y	25.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.19
Assets	$51.5M
Cash	$14.3M
Current Assets	$31.6M
Current Liabilities	$66.7M
Debt	$48.1M
Equity	$-23.2M
Interest Coverage	-5.13
Liabilities	$74.7M
Long Term Assets	$19.9M
Long Term Liabilities	$8M
Net Cash	$-33.9M
Net Cash By Market Cap	$-23.86
Tangible Book Value	$-28.6M
Tangible Book Value Per Share	$-0.93
WACC	14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.47
Inventory Turnover	1.86
Net Working Capital	$-3.1M
Quick ratio	0.36
Working Capital	$-35M
Working Capital Turnover	$-14.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.12%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-37.7%
1Y total return	-20.65%
200-day SMA	4.19
3Y total return	-75.5%
50-day SMA	4.35
50-day SMA vs 200-day SMA	50over200
5Y total return	-76.4%
All Time High	55.35
All Time High Change	-91.67%
All Time High Date	2020-02-19
All Time Low	3.22
All Time Low Change	43.17%
All Time Low Date	2026-01-07
ATR	0.4
Beta	1.86
Beta1y	1.09
Beta2y	1.55
Ch YTD	33.62
High	5.03
High52	7.12
High52 Date	2025-09-15
High52ch	-35.25%
Low	4.55
Low52	3.22
Low52 Date	2026-01-07
Low52ch	43.17%
Ma50ch	5.93%
Premarket Change Percent	-4.23
Premarket Price	$4.73
Premarket Volume	900
Price vs 200-day SMA	10%
RSI	51.14
RSI Monthly	42.68
RSI Weekly	51.98
Sharpe ratio	0.14x
Sortino ratio	0.3
Total Return	-11.12%
Tr YTD	33.62
Tr1m	14.39%
Tr1w	-7.43%
Tr3m	-1.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.37
Earnings Revenue Estimate	28,585,600x
Earnings Revenue Estimate Growth	55.2x
Operating Income	$-39.5M
Operating margin	-54.61
Price target	$9.07
Price Target Change	$96.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,301,797%
Float Percent	98.43%
Net Borrowing	6,097,000
Shares Insiders	1.57%
Shares Institutions	19%
Shares Out	30,783,605
Shares Qo Q	0.52%
Shares Yo Y	11.12%
Short Ratio	7.7
Short Shares	8.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-39.7M
Average Volume	400,287.3x
Bv Per Share	-0.75
CAPEX	$-803,000
Ch10y	-37.7
Ch1m	14.39
Ch1w	-7.43
Ch1y	-20.65
Ch3m	-1.28
Ch3y	-75.5
Ch5y	-76.4
Ch6m	11.62
Change	-6.68%
Change From Open	-3.56
Close	4.94
Days Gap	-3.24
Depreciation Amortization	2,400,000
Dollar Volume	858,229.9
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-39.5M
EBITDA	$-39.5M
EPS	$-1.57
F Score	2
FCF	$-31.8M
FCF EV Yield	-18.07x
FCF Per Share	$-1.03
Financing CF	20,670,000
Fiscal Year End	December
Income Tax	$-8,000
Investing CF	3,727,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2020-06-30
Last Split Type	Reverse
Last10k Filing Date	2026-02-12
Ma150	4.25
Ma150ch	8.6%
Ma20	4.59
Ma20ch	0.35%
Net CF	-6,561,000
Next Earnings Date	2026-08-06
Open	4.78
Optionable	Yes
Position In Range	13.4
Post Close	4.61
Postmarket Change Percent	4.45
Postmarket Price	$4.82
Ppne	10,877,000
Pre Close	4.94
Price Date	2026-07-23
Relative Volume	0.47x
Revenue	72,347,000x
SBC By Revenue	10.96x
Share Based Comp	7,926,000
Tax By Revenue	-0.01x
Tr6m	11.62%
Us State	California
Volume	186,167
Z Score	-12.14

AVITA Medical, Inc. (RCEL)

Coverage state: Market snapshot only — no published research

Generate the first RCEL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RCEL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RCEL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RCEL

Frequently asked questions